{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:28:12Z","timestamp":1791203292285,"version":"4.2.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.jmb.2009.07.031","type":"journal-article","created":{"date-parts":[[2009,7,18]],"date-time":"2009-07-18T09:02:15Z","timestamp":1247907735000},"page":"689-700","source":"Crossref","is-referenced-by-count":133,"title":["(\u2212)-Epigallocatechin-3-Gallate (EGCG) Maintains \u03ba-Casein in Its Pre-Fibrillar State without Redirecting Its Aggregation Pathway"],"prefix":"10.1016","volume":"392","author":[{"given":"Sean A.","family":"Hudson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heath","family":"Ecroyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis C.","family":"Dehle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian F.","family":"Musgrave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Carver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2009.07.031_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jmb.2009.07.031_bib2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/iub.117","article-title":"Unraveling the mysteries of protein folding and misfolding","volume":"60","author":"Ecroyd","year":"2008","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jmb.2009.07.031_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506120500032196","article-title":"Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis","volume":"12","author":"Westermark","year":"2005","journal-title":"Amyloid"},{"key":"10.1016\/j.jmb.2009.07.031_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrd769","article-title":"Therapeutic strategies for human amyloid diseases","volume":"1","author":"Sacchettini","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jmb.2009.07.031_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000385","article-title":"Novel therapeutic strategies for the treatment of protein-misfolding diseases","volume":"9","author":"Rochet","year":"2007","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.jmb.2009.07.031_bib6","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1742-4658.2006.05181.x","article-title":"Protein-misfolding diseases and chaperone-based therapeutic approaches","volume":"273","author":"Chaudhuri","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.jmb.2009.07.031_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0076-6879(06)13015-3","article-title":"Peptide-based inhibitors of amyloid assembly","volume":"413","author":"Sciarretta","year":"2006","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jmb.2009.07.031_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","article-title":"Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism","volume":"67","author":"Porat","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jmb.2009.07.031_bib9","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.2174\/138161208786404137","article-title":"Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease","volume":"14","author":"Yamin","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jmb.2009.07.031_bib10","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.2174\/138161208786404191","article-title":"Alpha-synuclein assembly as a therapeutic target of Parkinson's disease and related disorders","volume":"14","author":"Ono","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jmb.2009.07.031_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12035-008-8031-2","article-title":"Therapeutic strategies for Alzheimer's disease","volume":"37","author":"Barten","year":"2008","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jmb.2009.07.031_bib12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/092986606775338362","article-title":"Protein aggregation and its consequences for human disease","volume":"13","author":"Dobson","year":"2006","journal-title":"Prot. Peptide Lett."},{"key":"10.1016\/j.jmb.2009.07.031_bib13","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.bmc.2006.09.069","article-title":"Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro","volume":"15","author":"Riviere","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmb.2009.07.031_bib14","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1021\/jf051985c","article-title":"Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid","volume":"53","author":"Kim","year":"2005","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jmb.2009.07.031_bib15","first-page":"487","article-title":"Tea polyphenols, their biological effects and potential molecular targets","volume":"23","author":"Chen","year":"2008","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.jmb.2009.07.031_bib16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1753-4887.2007.tb00314.x","article-title":"Mechanisms and effects of green tea on cardiovascular health","volume":"65","author":"Basu","year":"2007","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.jmb.2009.07.031_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cbi.2007.02.008","article-title":"Proposed mechanisms of (\u2212)-epigallocatechin-3-gallate for anti-obesity","volume":"167","author":"Moon","year":"2007","journal-title":"Chem.-Biol. Interact."},{"key":"10.1016\/j.jmb.2009.07.031_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/187152907780830905","article-title":"Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection","volume":"7","author":"Tipoe","year":"2007","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"10.1016\/j.jmb.2009.07.031_bib19","doi-asserted-by":"crossref","first-page":"373S","DOI":"10.1080\/07315724.2007.10719626","article-title":"Effects of green tea and EGCG on cardiovascular and metabolic health","volume":"26","author":"Wolfram","year":"2007","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.jmb.2009.07.031_bib20","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.2174\/092986708785132979","article-title":"Green tea catechins and cardiovascular health: an update","volume":"15","author":"Babu","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jmb.2009.07.031_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.canlet.2008.04.014","article-title":"Multitargeted therapy of cancer by green tea polyphenols","volume":"269","author":"Khan","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jmb.2009.07.031_bib22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/187153008784534349","article-title":"Mechanisms underlying beneficial health effects of tea catechins to improve insulin resistance and endothelial dysfunction","volume":"8","author":"Kim","year":"2008","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"issue":"Suppl. 1","key":"10.1016\/j.jmb.2009.07.031_bib23","first-page":"245","article-title":"Cancer prevention by tea and tea polyphenols","volume":"17","author":"Yang","year":"2008","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"10.1016\/j.jmb.2009.07.031_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00204-008-0372-0","article-title":"Antioxidative and anti-carcinogenic activities of tea polyphenols","volume":"83","author":"Yang","year":"2009","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jmb.2009.07.031_bib25","doi-asserted-by":"crossref","first-page":"32176","DOI":"10.1074\/jbc.M806154200","article-title":"Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity","volume":"283","author":"Ono","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2009.07.031_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainres.2008.02.107","article-title":"Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice","volume":"1214","author":"Rezai-Zadeh","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.jmb.2009.07.031_bib27","first-page":"237","article-title":"The beneficial effect of (\u2212)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rat: a behavioral analysis","volume":"11","author":"Rasoolijazi","year":"2007","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.jmb.2009.07.031_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neurobiolaging.2007.05.012","article-title":"Epigallocatechin gallate (EGCG) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl\/FE65 nuclear translocation and GSK3 beta activation","volume":"30","author":"Lin","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jmb.2009.07.031_bib29","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/WNR.0b013e32830b8ae1","article-title":"Epigallocatechin-3-gallate and curcumin suppress amyloid beta-induced beta-site APP cleaving enzyme-1 upregulation","volume":"19","author":"Shimmyo","year":"2008","journal-title":"NeuroReport"},{"key":"10.1016\/j.jmb.2009.07.031_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JAD-2008-15207","article-title":"Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG)","volume":"15","author":"Mandel","year":"2008","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.jmb.2009.07.031_bib31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/156720507781788927","article-title":"Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG","volume":"4","author":"Avramovich-Tirosh","year":"2007","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jmb.2009.07.031_bib32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0024-3205(01)01438-2","article-title":"The green tea polyphenol (\u2212)-epigallocatechin gallate attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neurons","volume":"70","author":"Choi","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.jmb.2009.07.031_bib33","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1471-4159.2006.03770.x","article-title":"Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (\u2212)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease","volume":"97","author":"Reznichenko","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jmb.2009.07.031_bib34","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","article-title":"EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers","volume":"15","author":"Ehrnhoefer","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jmb.2009.07.031_bib35","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/hmg\/ddl210","article-title":"Green tea (\u2212)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models","volume":"15","author":"Ehrnhoefer","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jmb.2009.07.031_bib36","doi-asserted-by":"crossref","first-page":"9012","DOI":"10.1074\/jbc.M709928200","article-title":"Dissociation from the oligomeric state is the rate-limiting step in fibril formation by kappa-casein","volume":"283","author":"Ecroyd","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2009.07.031_bib37","doi-asserted-by":"crossref","first-page":"17027","DOI":"10.1021\/bi051352r","article-title":"Amyloid fibril formation by bovine milk kappa-casein and its inhibition by the molecular chaperones alphaS- and beta-casein","volume":"44","author":"Thorn","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2009.07.031_bib38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0301-4622(81)85018-1","article-title":"Some association properties of bovine SH-kappa-casein","volume":"14","author":"Vreeman","year":"1981","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.jmb.2009.07.031_bib39","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.3168\/jds.S0022-0302(93)77586-4","article-title":"Three-dimensional molecular modeling of bovine caseins: a refined, energy-minimized kappa-casein structure","volume":"76","author":"Kumosinski","year":"1993","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.jmb.2009.07.031_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1025020503769","article-title":"Environmental influences on bovine kappa-casein: reduction and conversion to fibrillar (amyloid) structures","volume":"22","author":"Farrell","year":"2003","journal-title":"J. Protein Chem."},{"key":"10.1016\/j.jmb.2009.07.031_bib41","series-title":"Dynamic Light Scattering By Macromolecules","author":"Schmitz","year":"1990"},{"key":"10.1016\/j.jmb.2009.07.031_bib42","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0021-9258(17)35225-0","article-title":"Specific detection of quinoproteins by redox-cycling staining","volume":"266","author":"Paz","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2009.07.031_bib43","doi-asserted-by":"crossref","first-page":"D629","DOI":"10.2741\/gutier","article-title":"The metabolism of quinone-containing alkylating agents: free radical production and measurement","volume":"5","author":"Gutierrez","year":"2000","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jmb.2009.07.031_bib44","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1007\/s00018-005-5397-4","article-title":"Chaperone-like features of bovine serum albumin: a comparison with alpha-crystallin","volume":"62","author":"Marini","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jmb.2009.07.031_bib45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6807-3-6","article-title":"Crystal structural analysis of human serum albumin complexed with hemin and fatty acid","volume":"3","author":"Zunszain","year":"2003","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.jmb.2009.07.031_bib46","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s10787-008-8031-x","article-title":"The challenge of developing green tea polyphenols as therapeutic agents","volume":"16","author":"Huo","year":"2008","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.jmb.2009.07.031_bib47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/mrc.2157","article-title":"Solid-state NMR analysis of the orientation and dynamics of epigallocatechin gallate, a green tea polyphenol, incorporated into lipid bilayers","volume":"46","author":"Kajiya","year":"2008","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.jmb.2009.07.031_bib48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nchembio.65","article-title":"Small-molecule aggregates inhibit amyloid polymerization","volume":"4","author":"Feng","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jmb.2009.07.031_bib49","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1016\/S0021-9258(18)94333-4","article-title":"The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis","volume":"244","author":"Weber","year":"1969","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2009.07.031_bib50","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jmb.2007.06.060","article-title":"Characterisation of amyloid fibril formation by small heat-shock chaperone proteins human alphaA-, alphaB- and R120G alphaB-crystallins","volume":"372","author":"Meehan","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2009.07.031_bib51","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jmb.2004.05.054","article-title":"Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity","volume":"340","author":"Rekas","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2009.07.031_bib52","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00018-008-8327-4","article-title":"Crystallin proteins and amyloid fibrils","volume":"66","author":"Ecroyd","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jmb.2009.07.031_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1096\/fj.01-0442hyp","article-title":"A possible role for pi-stacking in the self-assembly of amyloid fibrils","volume":"16","author":"Gazit","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.jmb.2009.07.031_bib54","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1111\/j.1742-4658.2005.05022.x","article-title":"Mechanisms of amyloid fibril self-assembly and inhibition. Model short peptides as a key research tool","volume":"272","author":"Gazit","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.jmb.2009.07.031_bib55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/13506120601116674","article-title":"The molecular mechanisms of the anti-amyloid effects of phenols","volume":"14","author":"Shoval","year":"2007","journal-title":"Amyloid"},{"key":"10.1016\/j.jmb.2009.07.031_bib56","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/archneurol.2007.56","article-title":"Protein misfolding and neurodegeneration","volume":"65","author":"Soto","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jmb.2009.07.031_bib57","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00109-003-0464-5","article-title":"Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution","volume":"81","author":"Stefani","year":"2003","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.jmb.2009.07.031_bib58","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.jmb.2009.07.031_bib59","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1021\/bi00742a007","article-title":"Selective reduction of cystine I\u2013VIII in alpha-lactalbumin of bovine milk","volume":"12","author":"Shechter","year":"1973","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2009.07.031_bib60","series-title":"Dairy Chemistry and Biochemistry","author":"Fox","year":"1998"},{"key":"10.1016\/j.jmb.2009.07.031_bib61","series-title":"All About Albumin: Biochemistry, Genetics, and Medical Applications","author":"Peters","year":"1995"},{"key":"10.1016\/j.jmb.2009.07.031_bib62","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0010-4655(82)90174-6","article-title":"CONTIN: a general purpose constrained regularization program for inverting noisy linear algebraic and integral equations","volume":"27","author":"Provencher","year":"1982","journal-title":"Comput. Phys. Commun."},{"key":"10.1016\/j.jmb.2009.07.031_bib63","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1063\/1.1678153","article-title":"Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants","volume":"57","author":"Koppel","year":"1972","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmb.2009.07.031_bib64","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1096\/fj.06-7986com","article-title":"The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures","volume":"21","author":"Yerbury","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.jmb.2009.07.031_bib65","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/prot.20995","article-title":"Interaction of (\u2212)-epigallocatechin-3-gallate with human serum albumin: fluorescence, Fourier transform infrared, circular dichroism, and docking studies","volume":"64","author":"Maiti","year":"2006","journal-title":"Proteins"}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283609008705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283609008705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T20:42:14Z","timestamp":1633725734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283609008705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0022283609008705"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2009.07.031","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}